leisure time -WSS

leisure time

author：focus 2025-09-09 19:29:37 - browse：59

3D DNA on a sheet of paper listing nucleic acid sequences — coverage from STAT — Adobe

Ultima Genomics, an upstart some observers have called a “dark horse” in the world of DNA sequencing, will soon launch a line of high-power instruments that can read a human genome for as little as $100, the company’s leadership told STAT.

The sequencer, dubbed the UG 100, is a $1.5 million machine that can read up to 20,000 human genomes a year. The reagents required to operate the instrument cost as little as $1 per billion sequenced DNA bases; that translates to $100 per genome assuming each base in the 3-gigabase human genome is read 33 times, a common industry standard. The company plans to officially launch the product at this year’s Advances in Genome Biology and Technology meeting, which kicks off in Orlando, Fla., on Feb. 5.

The product’s cost and maximum output put it roughly in the same range as a line of high-throughput instruments launched in September 2022 by Illumina, which controls an estimated 80% of the sequencing market. But Ultima is hoping it can chip into the sequencing giant’s market share among genome centers, large clinical labs, and others with an appetite for reams of genetic data by offering lower operating costs and greater flexibility.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Ventyx halts psoriasis drug development after lackluster trial results

WSS

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

Medicare to cover more brain scans for Alzheimer’s patients

Listen: Wegovy in the brain & pivotal Alzheimer's data

FDA reorg will put new emphasis on investigations, sources say

Weight loss drugs should be covered by insurers, AMA says

As digital health tech proliferates, a new institute aims to cut through hype

explore

leisure time

Wikipedia

Drug repurposing or repositioning? The language matters

What is STAT's opinion section for?

Moonlake's readout produced a cash windfall. Risks remain

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

At least 13 dead in Texas as scorching temps continue

Cancer diagnosis changes perspective doctor, former hospital CEO

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Carbon Health diabetes program, a test of data

Drug repurposing or repositioning? The language matters

Doctors find melanoma drugs effective against rare brain cancer

leisure time

UnitedHealth sued over use of algorithm in Medicare Advantage plans

UnitedHealth sued over use of algorithm in Medicare Advantage plans

Carbon Health diabetes program, a test of data

UnitedHealth sued over use of algorithm in Medicare Advantage plans

Publishing genetic code of viruses could cause disaster

FDA approves RSV monoclonal antibody for infants, toddlers

focus

entertainment

knowledge

focus